ReleaseWire Connect

An investor, who currently holds shares of Mavenir Systems Inc (NYSE:MVNR), filed a lawsuit in effort to stop the proposed takeover of Mavenir Systems Inc by Mitel for a value of $17.94 per share.

An investigation on behalf of investors of E Commerce China Dangdang Inc (ADR) (NYSE:DANG) shares over potential securities laws violations by E Commerce China Dangdang Inc and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors in NASDAQ:ACRX shares whether AcelRx Pharmaceuticals Inc and certain of its officers and/or directors have potentially violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 was announced.

An investigation on behalf of investors, who currently hold shares of Bridge Capital Holdings (NASDAQ:BBNK), was announced concerning whether the takeover of Bridge Capital Holdings by Western Alliance Bancorporation is unfair to NASDAQ:BBNK stockholders.

An investigation for investors, who currently hold shares of Trinity Industries Inc (NYSE:TRN) Long-term, is ongoing concerning potential breaches of fidruciary duties by certain Trinity Industries officers and directors that caused the company and its shareholders financial damages.

An investigation on behalf of investors of Accelerate Diagnostics Inc (NASDAQ:AXDX) shares over potential securities laws violations by Accelerate Diagnostics and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of investors who currently hold shares of Magnachip Semiconductor Corp (NYSE:MX) long-term was announced concerning potential wrongdoing by certain officers and directors at Magnachip Semiconductor.

An investigation on behalf of investors of Pilgrim's Pride Corporation (NASDAQ:PPC) shares over potential securities laws violations was announced.

An investigation on behalf of investors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares over potential securities laws violations by ACADIA Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of current long-term investors in shares of MiMedx Group Inc (NASDAQ:MDXG) concerning potential breaches of fiduciary duties by certain directors and officers of MiMedx Group Inc was announced.